
Data How is a pioneering company in AI-enabled bioprocess development, transforming how bioprocesses are developed and operated. They offer innovative technologies that enhance efficiency and effectiveness in bioprocessing, allowing for higher yields, greater robustness, and improved product quality while reducing time and costs. Trusted by 12 of the top 20 Big Pharma companies, Data How has established itself as a thought leader in hybrid modeling technology for bioprocess systems, providing a holistic solution through their Data How Lab platform.

Data How is a pioneering company in AI-enabled bioprocess development, transforming how bioprocesses are developed and operated. They offer innovative technologies that enhance efficiency and effectiveness in bioprocessing, allowing for higher yields, greater robustness, and improved product quality while reducing time and costs. Trusted by 12 of the top 20 Big Pharma companies, Data How has established itself as a thought leader in hybrid modeling technology for bioprocess systems, providing a holistic solution through their Data How Lab platform.
Founded: 2017 (ETH Zurich spin-off)
Core product: DataHowLab — AI-enabled hybrid modeling platform for bioprocess development
Headquarters: Zurich (additional offices: Lisbon, Milan, Philadelphia)
Employees: 44 (reported)
Latest funding: Series A (May–June 2024) led by Momenta
Bioprocess development and manufacturing analytics
2017
Data Infrastructure and Analytics
Round announced/closed May–June 2024 with participation from Rockwell Automation and Zürcher Kantonalbank
“Led by Momenta with participation from Rockwell Automation and Zürcher Kantonalbank”
| Company |
|---|